Chromos Enters into Agreement with Centocor For Development of Cell Lines For Production of Therapeutic Proteins
20-Aug-2004 -
Burnaby, British Columbia, Canada. Chromos Molecular Systems Inc. announced that is has entered into a collaborative agreement with Centocor Inc., of Malvern, Pennsylvania, a wholly owned subsidiary of Johnson & Johnson, to develop cell lines using the Artificial Chromosome Expression (ACE) ...
biopharmaceuticals
cell lines
Expression
+3